Stepan (SCL) Aandelenoverzicht
Samen met haar dochterondernemingen produceert en verkoopt Stepan Company chemische specialiteiten en tussenproducten aan andere fabrikanten voor gebruik in verschillende eindproducten in de Verenigde Staten, Frankrijk, Polen, het Verenigd Koninkrijk, Brazilië en Mexico. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 5/6 |
| Toekomstige groei | 3/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 3/6 |
| Dividenden | 3/6 |
Beloningen
Risicoanalyse
SCL Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Stepan Company Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$51.92 |
| 52 Week Hoogtepunt | US$68.00 |
| 52 Week Laag | US$41.82 |
| Bèta | 0.95 |
| 1 maand verandering | -0.97% |
| 3 maanden verandering | -19.74% |
| 1 Jaar Verandering | -7.05% |
| 3 jaar verandering | -42.91% |
| 5 jaar verandering | -62.13% |
| Verandering sinds IPO | 9,566.57% |
Recent nieuws en updates
Recent updates
SCL: Stable Margins And Buybacks Will Support Long-Term Dividend Upside
Analysts kept their fair value estimate steady at $75, with only marginal tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions. This indicates a largely unchanged view of Stepan's longer term potential.SCL: Stable Margins And Buyback Completion Will Support Long-Term Dividend Upside
Analysts have nudged their Stepan price target slightly higher to $75.00, with modest tweaks to the discount rate and P/E assumptions supporting this updated view. What's in the News For the three months ended December 31, 2025, Stepan Company reported unaudited goodwill impairment of $6,245,000, which directly affects reported earnings quality for that period (Key Developments).Stepan Company: The Ride Higher Isn't Over Yet
Summary Stepan Company (SCL) is reaffirmed as a 'buy' due to compelling valuation and significant cost-saving initiatives. SCL's Project Catalyst targets $100M in pre-tax savings over two years, with 60% expected in the current year. Despite mixed profitability and cash flow, SCL remains attractively priced versus peers, especially on cash flow metrics. Even if cost savings underdeliver, current valuation provides downside protection and long-term upside potential. Read the full article on Seeking AlphaSCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside
Analysts have maintained their Stepan fair value estimate at $75.00, making only small adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions. This signals that their overall view on the stock’s longer-term potential remains largely unchanged.SCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside
Analysts have modestly revised their price outlook for Stepan, keeping fair value around $75.00 while making small tweaks to the discount rate and projected P/E. This reflects updated assumptions about the risk profile and valuation multiples rather than a shift in the underlying growth or margin view.SCL: Higher Future P/E Assumptions Will Support Long-Term Dividend Upside
Analysts have adjusted their Stepan price target to $75.00, with the change tied to updated views on discount rate, revenue growth, profit margin, and a higher assumed future P/E multiple. What's in the News Stepan Company reported an unaudited goodwill impairment of $6,245,000 for the three months ended December 31, 2025.SCL: Refined Discount Rate Assumptions Will Support Long-Term Dividend Upside
Analysts have kept their Stepan price target steady at $75.00, citing only slight tweaks to assumptions like discount rate, revenue growth, profit margin, and future P/E that were not material enough to change their overall valuation view. Valuation Changes Fair Value: Steady at $75.00, indicating no change in the analysts' central valuation estimate.Why Investors Shouldn't Be Surprised By Stepan Company's (NYSE:SCL) 26% Share Price Surge
Despite an already strong run, Stepan Company ( NYSE:SCL ) shares have been powering on, with a gain of 26% in the last...SCL: Higher Discount Rate Will Set Up Attractive Long-Term Dividend Returns
Analysts now estimate Stepan's fair value at US$75.00, reduced from US$82.21. This change reflects updated assumptions regarding a higher discount rate, revised profit margin expectations, a slightly higher revenue growth outlook, and a lower future P/E multiple.Stepan (NYSE:SCL) May Have Issues Allocating Its Capital
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...Why Stepan Company (NYSE:SCL) Could Be Worth Watching
Stepan Company ( NYSE:SCL ), is not the largest company out there, but it saw a double-digit share price rise of over...Stepan (NYSE:SCL) Will Pay A Larger Dividend Than Last Year At $0.395
Stepan Company's ( NYSE:SCL ) periodic dividend will be increasing on the 15th of December to $0.395, with investors...Here's What's Concerning About Stepan's (NYSE:SCL) Returns On Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Is It Time To Consider Buying Stepan Company (NYSE:SCL)?
While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...Earnings Tell The Story For Stepan Company (NYSE:SCL)
Stepan Company's ( NYSE:SCL ) price-to-earnings (or "P/E") ratio of 22.5x might make it look like a sell right now...Results: Stepan Company Exceeded Expectations And The Consensus Has Updated Its Estimates
A week ago, Stepan Company ( NYSE:SCL ) came out with a strong set of first-quarter numbers that could potentially lead...Stepan Company's Plunge Offers Investors A Chance To Clean Up
Summary Markets are inefficient short-term, creating opportunities for logical, value-oriented investors; Stepan Company is now a ‘buy’ due to recent price drops and management's positive outlook. Despite a 6% revenue drop in 2024, Stepan Company improved net income and EBITDA, driven by cost-cutting measures and productivity improvements. Management is optimistic about 2025, expecting volume growth, margin improvement, and positive free cash flow, targeting high-margin, growth-oriented markets. Analysts forecast revenue and earnings growth for Q1 2025; shares are attractively priced compared to peers, justifying an upgrade to a ‘buy’ rating. Read the full article on Seeking AlphaShould You Investigate Stepan Company (NYSE:SCL) At US$47.60?
While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...Stepan Company: A 'Moderate Buy' Despite A High Valuation
Summary Stepan Company, a specialty chemicals manufacturer, excels in operational efficiency and dividend growth, making it a stable investment despite current valuations. Q3 FY24 financials show margin expansion and significant net income growth, despite a 3% revenue decline, highlighting fiscal discipline. Trading at a forward P/E of 17.3x for 2025, Stepan's stock has a potential 26% upside, making it a promising investment opportunity. I am an investment analyst with a focus on income generation. Read the full article on Seeking AlphaShareholders Should Be Pleased With Stepan Company's (NYSE:SCL) Price
With a price-to-earnings (or "P/E") ratio of 31.4x Stepan Company ( NYSE:SCL ) may be sending very bearish signals at...These 4 Measures Indicate That Stepan (NYSE:SCL) Is Using Debt Extensively
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Stepan's (NYSE:SCL) Upcoming Dividend Will Be Larger Than Last Year's
The board of Stepan Company ( NYSE:SCL ) has announced that the dividend on 13th of December will be increased to...Stepan Company: Not A Great Performance, But Good Value
Summary Stepan Company, despite underperformance and volatility, has long-term upside due to its unique position in the specialty chemicals market, particularly surfactants. The company's fundamentals have improved with reduced CapEx and positive FCF, but current earnings and macro pressures persist. SCL's growth potential is tied to the surfactant segment and market diversification, though the timing of earnings recovery remains uncertain. I rate Stepan as a "Buy" with a $90 PT, but caution that there are superior investments in the chemicals sector with better returns. Read the full article on Seeking Alpha
Calculated Supply Chain And Market Expansion Drive Robust Growth And Margin Improvement
Operational cost reductions and workforce productivity improvements aim to positively impact net margins.Some Investors May Be Worried About Stepan's (NYSE:SCL) Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...Stepan (NYSE:SCL) Takes On Some Risk With Its Use Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Stepan Company Is Making Great Progress
Summary Stepan Company faced declining revenue, profits, and cash flows due to weak demand and inventory destocking, leading to a 'hold' rating. Despite a difficult 2023, the company showed improvements in cash flows and margins in the first quarter of 2024. Analysts expect revenue and earnings per share to improve in the second quarter of 2024, but shares are not yet attractively priced for an upgrade. Read the full article on Seeking AlphaWhen Should You Buy Stepan Company (NYSE:SCL)?
Stepan Company ( NYSE:SCL ), is not the largest company out there, but it saw a decent share price growth of 11% on the...Rendement voor aandeelhouders
| SCL | US Chemicals | US Markt | |
|---|---|---|---|
| 7D | 2.2% | 1.7% | 2.6% |
| 1Y | -7.1% | 9.6% | 26.2% |
Rendement versus industrie: SCL presteerde slechter dan de US Chemicals -sector, die het afgelopen jaar een rendement van 9.6 % opleverde.
Rendement versus markt: SCL presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 26.2 % opleverde.
Prijsvolatiliteit
| SCL volatility | |
|---|---|
| SCL Average Weekly Movement | 7.2% |
| Chemicals Industry Average Movement | 7.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.2% |
Stabiele aandelenkoers: SCL heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 7% ) van SCL is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1932 | 2,328 | Luis Rojo | www.stepan.com |
Stepan Company produceert en verkoopt samen met haar dochterondernemingen chemische specialiteiten en tussenproducten aan andere fabrikanten voor gebruik in verschillende eindproducten in de Verenigde Staten, Frankrijk, Polen, het Verenigd Koninkrijk, Brazilië en Mexico. Het bedrijf is actief in drie segmenten: Oppervlakte-actieve stoffen, Polymeren en Speciale producten. Het segment Oppervlakte-actieve stoffen biedt oppervlakte-actieve stoffen die worden gebruikt in reinigings- en ontsmettingsproducten voor consumenten en industrie, waaronder wasmiddelen voor het wassen van kleding, vaat, tapijten, vloeren en muren, shampoos en bodywash; en andere toepassingen, zoals wasverzachters, kiemdodende quaternaire verbindingen, ontsmettingsmiddelen, smeermiddelen; emulgatoren voor het verspreiden van landbouwproducten; en industriële toepassingen waaronder latexsystemen, kunststoffen en composieten.
Stepan Company Samenvatting
| SCL fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$1.20b |
| Inkomsten(TTM) | -US$14.22m |
| Inkomsten(TTM) | US$2.34b |
Is SCL overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| SCL resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$2.34b |
| Kosten van inkomsten | US$2.08b |
| Brutowinst | US$259.28m |
| Overige uitgaven | US$273.50m |
| Inkomsten | -US$14.22m |
Laatst gerapporteerde inkomsten
Mar 31, 2026
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.63 |
| Brutomarge | 11.06% |
| Nettowinstmarge | -0.61% |
| Schuld/Eigen Vermogen Verhouding | 54.6% |
Hoe presteerde SCL op de lange termijn?
Bekijk historische prestaties en vergelijkingDividenden
Betaalt SCL een betrouwbaar dividend?
Zie SCL dividendgeschiedenis en benchmarks| Stepan dividenddata | |
|---|---|
| Ex Dividend Datum | Jun 01 2026 |
| Betaaldatum dividend | Jun 15 2026 |
| Dagen tot Ex-dividend | 20 days |
| Dagen tot dividendbetaaldatum | 34 days |
Betaalt SCL een betrouwbaar dividend?
Zie SCL dividendgeschiedenis en benchmarksBedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/11 10:09 |
| Aandelenkoers aan het einde van de dag | 2026/05/11 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Stepan Company wordt gevolgd door 4 analisten. 2 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Michael Harrison | Seaport Research Partners |
| Daniel Rizzo | Sidoti & Company, LLC |
| Vincent Anderson | Stifel, Equities Research |